Literature DB >> 19578387

Transformation of human liver L-O2 cells mediated by stable HBx transfection.

Wei-ying Zhang1, Na Cai, Li-hong Ye, Xiao-dong Zhang.   

Abstract

AIM: To explore the mechanism of hepatocarcinogenesis associated with the hepatitis B virus X protein (HBx), we investigated the role of HBx in transformation using human liver L-O2 cells stably transfected with HBx as a model.
METHODS: Plasmids encoding HBx were stably transfected into immortalized human liver L-O2 cells and rodent fibroblast NIH/3T3 cells. The expression of alfa-fetoprotein (AFP), c-Myc, HBx, and survivin in the engineered cells was examined by Western blotting. The malignant phenotype of the cells was demonstrated by anchorage-independent colony formation and tumor formation in nude mice. RNA interference assays, Western blotting, luciferase reporter gene assays and flow cytometry analysis were performed. The number of centrosomes in the L-O2-X cells was determined by gamma-tubulin immunostaining. The effect of HBx on the transcriptional activity of human telomerase reverse transcriptase (hTERT) and hTERT activity in L-O2-X cells and/or 3T3-X cells was detected by the luciferase reporter gene assay and telomerase repeat amplification protocol (TRAP).
RESULTS: Stable HBx transfection resulted in a malignant phenotype in the engineered cells in vivo and in vitro. Meanwhile, HBx was able to increase the transcription of the NF-kappaB, AP-1, and survivin genes and to upregulate the expression levels of c-Myc and survivin. Abnormal centrosome duplication and activated hTERT were responsible for the transformation.
CONCLUSION: Stable HBx transfection leads to genomic instability of host cells, which is responsible for hepatocarcinogenesis; meanwhile, transactivation by the HBx protein contributes to the development of hepatocellular carcinoma (HCC). The L-O2-X cell line is an ideal model for investigating the mechanism of HBx-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578387      PMCID: PMC4006685          DOI: 10.1038/aps.2009.99

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  49 in total

Review 1.  Genetic mechanisms of hepatocarcinogenesis.

Authors:  Mark A Feitelson; Bill Sun; N Lale Satiroglu Tufan; Jie Liu; Jingbo Pan; Zhaorui Lian
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

2.  Mechanism for the reduction of telomerase expression during muscle cell differentiation.

Authors:  K Nozawa; K Maehara; K Isobe
Journal:  J Biol Chem       Date:  2001-03-28       Impact factor: 5.157

3.  X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.

Authors:  J Diao; A A Khine; F Sarangi; E Hsu; C Iorio; L A Tibbles; J R Woodgett; J Penninger; C D Richardson
Journal:  J Biol Chem       Date:  2000-11-30       Impact factor: 5.157

4.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.

Authors:  Enrique Lara-Pezzi; Maria Victoria Gómez-Gaviro; Beatriz G Gálvez; Emilia Mira; Miguel A Iñiguez; Manuel Fresno; Carlos Martínez-A; Alicia G Arroyo; Manuel López-Cabrera
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.

Authors:  Y C Kim; K S Song; G Yoon; M J Nam; W S Ryu
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

6.  Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.

Authors:  Vassiliki Kotoula; Prodromos Hytiroglou; Athina Pyrpasopoulou; Romil Saxena; Swan N Thung; Constantine S Papadimitriou
Journal:  Liver       Date:  2002-02

Review 7.  Hepatocellular carcinoma.

Authors:  K Okuda
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

8.  Upstream binding factor up-regulated in hepatocellular carcinoma is related to the survival and cisplatin-sensitivity of cancer cells.

Authors:  Ruimin Huang; Tangming Wu; Liang Xu; Aihua Liu; Yuan Ji; Gengxi Hu
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

9.  Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier.

Authors:  Nan-Hong Tang; Yian-Ling Chen; Xiao-Qian Wang; Xiu-Jin Li; Feng-Zhi Yin; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  Gene expression profiles of human liver cells mediated by hepatitis B virus X protein.

Authors:  Wei-ying Zhang; Fu-qing Xu; Chang-liang Shan; Rong Xiang; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

View more
  17 in total

1.  Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway.

Authors:  Lihong Shen; Xifeng Zhang; Daixi Hu; Tao Feng; Hongli Li; Yongliang Lu; Jiayi Huang
Journal:  Mol Cell Biochem       Date:  2013-08-10       Impact factor: 3.396

2.  Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells.

Authors:  Lei Li; Hong-Hai Hong; Shi-Ping Chen; Cai-Qi Ma; Han-Yan Liu; Ya-Chao Yao
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

3.  Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2.

Authors:  Guang-yao Kong; Jun-ping Zhang; Shuai Zhang; Chang-liang Shan; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

4.  Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.

Authors:  Guangyao Kong; Junping Zhang; Shuai Zhang; Changliang Shan; Lihong Ye; Xiaodong Zhang
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

5.  Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.

Authors:  Lin Ding; Jun-Lin Liu; Waseem Hassan; Lu-Lu Wang; Fang-Rong Yan; Jing Shang
Journal:  Sci Rep       Date:  2014-05-06       Impact factor: 4.379

Review 6.  Hepatitis B virus X protein accelerates the development of hepatoma.

Authors:  Xiao-Dong Zhang; Yuan Wang; Li-Hong Ye
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

7.  Hepatitis B virus X protein up-regulates C4b-binding protein α through activating transcription factor Sp1 in protection of hepatoma cells from complement attack.

Authors:  Guoxing Feng; Jiong Li; Minying Zheng; Zhe Yang; Yunxia Liu; Shuqin Zhang; Lihong Ye; Weiying Zhang; Xiaodong Zhang
Journal:  Oncotarget       Date:  2016-05-10

8.  Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.

Authors:  Weiying Zhang; Zhanping Lu; Guangyao Kong; Yuen Gao; Tao Wang; Qi Wang; Na Cai; Honghui Wang; Fabao Liu; Lihong Ye; Xiaodong Zhang
Journal:  Mol Cancer       Date:  2014-05-28       Impact factor: 27.401

Review 9.  MicroRNAs associated with HBV infection and HBV-related HCC.

Authors:  Kun-Lin Xie; Yan-Ge Zhang; Jun Liu; Yong Zeng; Hong Wu
Journal:  Theranostics       Date:  2014-09-19       Impact factor: 11.556

10.  Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.

Authors:  Mingyue Zhu; Yan Lu; Wei Li; Junli Guo; Xu Dong; Bo Lin; Yi Chen; Xieju Xie; Mengsen Li
Journal:  J Cancer       Date:  2016-05-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.